GLOBAL INNOVATOR IN SMART ULTRASOUND
A VISION BEYOND “GOOD ENOUGH”
Ever since its founding in 2005, Signostics has sought to pioneer new possibilities in the field of point‑of‑care ultrasound diagnostics.
Clinicians had long been accustomed to using conventional handheld scanners to measure bladder volume. From their home base in Adelaide, Australia, the technologists at Signostics recognised how much more could be achieved through adoption of advances in microprocessing and software.
ACCELERATED BY KKR
Now under the leadership of CEO and industry pioneer Kevin Goodwin, Signostics has gained recognition and $35 million in funding though a capital commitment from the global investment firm KKR.
KKR’s investment is enabling Signostics to assemble the talent and infrastructure for the next wave of intelligent point‑of‑care ultrasound diagnostics, with enhanced feature recognition and analysis.
Signostics seeks to place the power of smart ultrasound diagnostics in the hands of more practitioners and facilities everywhere, to benefit an ever widening range of patients.
“KKR offers us the privilege of working with a highly regarded long-term capital partner, which will enable us to create next-level innovations, aimed at greater disruption and democratisation of the global ultrasound market.”
HIGH ACHIEVEMENT IN A SHORT SPAN
Since the global commercialisation of its first device in 2009, Signostics has worked to leverage science from computer vision algorithms. Signostics technology has made a breakthrough with the introduction of Uscan, advanced ultrasound for bladder care.
BUILDING THE FUTURE OF ULTRASOUND
CEO and ultrasound pioneer Kevin Goodwin discusses the present and future roles of Signostics in advancing patient care through intelligent ultrasound diagnostics.